CCL3 and myeloid sarcoma: A mild association was found between CCL-3 levels and the WM lesion volume, since MS patients with the highest WMLV had also higher CCL-3 CSF concentrations (0.79 ± 0.35 vs. 0.59 ± 0.79, p = 0.03).